Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 19, 2026.

Cellular and molecular roles of reactive oxygen species in wound healing

Matthew Hunt, Monica Torres, Etty Bachar-Wikstrom and 1 more

Communications Biology · 2024 · Review · CC BY

doi:10.1038/s42003-024-07219-w

Abstract

Wound healing is a highly coordinated spatiotemporal sequence of events involving several cell types and tissues. The process of wound healing requires strict regulation, and its disruption can lead to the formation of chronic wounds, which can have a significant impact on an individual’s health as well as on worldwide healthcare expenditure. One essential aspect within the cellular and molecular regulation of wound healing pathogenesis is that of reactive oxygen species (ROS) and oxidative stress. Wounding significantly elevates levels of ROS, and an array of various reactive species are involved in modulating the wound healing process, such as through antimicrobial activities and signal transduction. However, as in many pathologies, ROS play an antagonistic pleiotropic role in wound healing, and can be a pathogenic factor in the formation of chronic wounds. Whilst advances in targeting ROS and oxidative stress have led to the development of novel pre-clinical therapeutic methods, due to the complex nature of ROS in wound healing, gaps in knowledge remain concerning the specific cellular and molecular functions of ROS in wound healing. In this review, we highlight current knowledge of these functions, and discuss the potential future direction of new studies, and how these pathways may be targeted in future pre-clinical studies.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 20, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Dermatological would healing is the tightly coordinated response of restoring skin tissue integrity and homeostasis following damage. Involving numerous immune and non-immune cell types as well as associated cytokines, growth factors, and extracellular components – in a healthy, acute response – orderly wound healing consists of the four consecutive stages of haemostasis, inflammation, proliferation, and tissue remodelling,. Briefly, during the haemostasis phase, platelets are recruited or leak out of damaged vasculature and with the simultaneous activation of the coagulation cascade and formation of fibrin fibres, form a clot at the wound site. Next, during inflammation, various immune cells migrate to the wound site and utilise phagocytotic effects to protect against infection. Additionally, these immune cells also release pro-inflammatory cytokines and growth factors to induce the activation of fibroblasts, keratinocytes, and endothelial cells, as well as prepare the wound bed for the formation of granulation tissue,. During the proliferation phase, granulation tissue is formed and damaged tissue is replaced. At the remodelling phase, connective tissue, replacement epithelium, and scar tissue are all formed.

Reactive oxygen species (ROS) play an essential pleiotropic role in wound healing, and several ROS are involved in the wound healing milieu (Fig. 1). These include superoxide (O2.−), hydroxyl radicals (.OH) and ions (OH−), hydrogen peroxide (H2O2), and peroxide (.O2−2). ROS are implicated in numerous pathophysiological functions within the wound healing process such as anti-bacterial activities,, as well as acting as secondary messengers in signalling cascades to modulate chemotaxis, angiogenesis, cell growth and migration, stem cell fate, and extracellular matrix (ECM) deposition,–.

Importantly, both the levels and timing of ROS production need to be tightly regulated for efficient wound healing. Too high levels caused by either excess ROS production or impaired detoxification lead to oxidative stress, elevated tissue damage, and pathophysiological stalling,, whilst too low levels impede cellular and molecular processes of wound healing which are dependent on ROS-mediated signal transduction – ultimately leading to the formation of chronic wounds. Highlighting the delicate and complex balance required, inhibition of ROS has been shown to impair wound healing in numerous animal models–, whilst improvements in antioxidant capabilities have been shown to be beneficial in treatments of chronic and diabetic wounds,,. As such, due to the multifaceted nature of chronic wound pathogenesis and susceptibility to abnormalities in ROS balance, interest in the role of ROS in wound healing, as well as the potential applicability of targeting ROS therapeutically, has grown significantly in recent years. However, it will be essential to further elucidate the precise signalling pathways and mechanisms in which ROS is involved in wound healing. Thus, in this review, we discuss the current knowledge of the cellular and molecular roles of ROS in wound healing and chronic wound pathogenesis, as well as evaluate recent advances in pre-clinical therapeutic approaches targeting ROS and oxidative stress.

Physiological functions of ROS

ROS encompass both free-radical or non-radical derivative (peroxides) oxygen intermediates generated by plasma membrane proteins (Fig. 2). Physiologically, as well as in pathologies such as wound healing, H2O2 is recognised as the predominant paracrine ROS secondary messenger involved in signalling cascades,. This is due to the fact that H2O2 can quickly and readily diffuse through cell membranes, primarily through aquaporins (AQPs),, as well as between neighbouring cells through gap junctions – hemichannels composed of connexins which facilitate the transfer of molecules 1–3 kDa large such as ROS between cells to propagate oxidative signals. Additionally, ROS can directly modulate post-transcriptional gene regulation by interacting and reversibly oxidising thiolate groups and methionine, as well as activating mitosis-related signal transduction pathways,, and electron-rich cysteine residues.

The main sources of intracellular H2O2 are NADPH oxidases (NOXs) and dual-oxidases (DUOXs)–, in conjunction with superoxide dismutases (SOD), as well as at the mitochondrial electron transport chain (ETC), – highlighting an important aspect of mitochondria within wound healing. Collectively, NOXs and the ETC generate roughly 85% of H2O2, with the remaining production deriving from oxidases in the endoplasmic reticulum (ER) and peroxisomes, as well as from cumulative environmental stressors such as UV or ionising radiation,,,. Additionally, membrane-bound NOXs are also responsible for producing.O2.− utilised in antimicrobial activities. Other ROS are produced by cytosolic enzymes such as cyclooxygenase, or during lipid metabolism within peroxisomes.

As previously mentioned, whilst low to moderate physiological levels of ROS are beneficial for several processes of wound healing pathophysiology, excess ROS can be deleterious. To counteract these harmful effects, a variety of antioxidant enzymes play vital roles in maintaining ROS levels, termed redox balance. These include peroxiredoxins such as catalase (CAT), glutathione peroxidases,, and mitochondrial nicotinamide nucleotide transhydrogenase (NNT), which act as ‘sinks’ to remove H2O2 and maintain non-deleterious physiological levels. In addition, SOD, of which there are four isoforms in humans, are antioxidant metalloproteinases which regulate levels of O2.−. In particular, the mitochondrial SOD (MnSOD/SOD2) converts.O2.− into H2O2, which is less reactive than.O2.− and so can readily be used for cellular signalling. As SOD2 is induced by hypoxia and subsequent HIF-1α activation, it is highly upregulated after wounding,.

Oxidative stress is the state induced by an overbalance in the form of excess ROS, and can be a causative factor in chronic wound formation, as well as in the pathogenesis of other diseases including cancers, cardiovascular diseases, Parkinson’s, obesity, and other clinically-relevant age-related diseases–. In the context of wound healing, oxidative stress can lead to the existence of a prolonged pro-inflammatory environment as well as dysregulated re-epithelialisation, as discussed in the following sections.

Finally, another important free radical is nitric oxide (NO), which is a reactive nitrogen species (RNS) involved in vascularisation, inflammation, and antimicrobial activities in wound healing–. Most importantly with regards to wound healing, NO plays an important role in pathogen clearance during the inflammatory stage, and this NO is produced by the inducible nitric oxide synthase (iNOS) isozyme,. Here, NO targets both gram-negative and -positive bacteria through aberrant peroxidation and the production of ONOO-, although this can be hindered by its short half-life,. Alternatively, lower levels of NO, produced by endothelial nitric oxide synthase (eNOS), play important roles in preventing platelet adhesion to vessel walls during haemostasis, and for both keratinocyte and fibroblast proliferation, motility, and differentiation at the later proliferation and tissue remodelling stages of wound healing–. Insufficient production of NO has been shown to be a significant factor in the development of chronic wounds such as diabetic foot ulcer (DFU), primarily due to resultant impaired antimicrobial activities,.

ROS and leucocyte recruitment

Immediately following skin wounding there is a peak in ROS production to ~0.5–50 μM. Here, ROS are utilised to simultaneously recruit leucocytes to the wound site, as well as to induce vasoconstriction,,. Through studies of ROS dynamics in embryonic zebrafish wounding, Niethammer et al. demonstrated for the first time that epithelial cell production of H2O2 preceded the recruitment of leucocytes, and in particular that DUOX was the main source of H2O2 at the wound site and inducer of rapid leucocyte recruitment from long distances. In embryonic Drosophila, the activation of DUOX and subsequent H2O2 production was shown to be triggered by wound-induced calcium (Ca2+) flashes, where Ca2+ binds to an EF hand Ca2+-binding motif of DUOX.

Expanding on this work, Yoo et al. demonstrated the cystine residue C466 on the Src family kinase Lyn as being the direct target of H2O2 to induce neutrophil recruitment to the wound site, mediated through ERK signalling. Alternatively, the activation of DUOXs, with subsequent H2O2 production and neutrophil recruitment, can also be activated by ATP through the P2Y receptor (P2YR)/phospholipase C (PLC) Ca2+ signalling pathway following wounding in embryonic zebrafish tailfins.

ROS and macrophage function

Macrophages play important roles within the wound healing process, including in antimicrobial activities, as well as inflammation, angiogenesis, anti-inflammation, re-epithelialisation, and tissue resolution. ROS-induced HIF-1α stabilisation leads to the activation of macrophages in the early stages of wound healing, and promotes metabolic reprogramming towards glycolysis,, as well as increased angiogenesis. Importantly, both NOX1- and NOX2-produced ROS are required for the activation and differentiation of monocytes into proinflammatory M1 and anti-inflammatory M2 macrophages. Additionally, in atherosclerotic lesions, NOX4-produced ROS drives monocyte and macrophage cell death – a vital step required to prevent prolonged inflammation in wound healing.

Although NOXs are essential for macrophage activation, they have been shown to be dispensable for M1 macrophage-mediated proinflammatory cytokine production. Instead, pro-inflammatory cytokine production and inflammasome activation in macrophages predominantly relies on the regulation of the Nrf2 response, which can be primarily activated by glutathione or thioredoxin systems, as well as to a lesser extent NOXs. Other important pro-inflammatory signalling pathways regulated by ROS – and in particular H2O2 – include p38-MAPK-mediated NF-κB/HIF-1α,, and JAK-STAT pathways.

Monoamine oxidases (MAOs) – a mitochondrially-located enzyme responsible for catalysing the oxidative deamination of H2O2 – is upregulated by the M2 macrophage-activating IL-13 and IL-4, or LPS signals. This process is mediated through JAK signalling pathways and is thus important in anti-inflammation and re-epithelialisation during wound healing. Indeed, MAO inhibitors significantly reduced H2O2 levels and NF-κB/TNFα activation to impair apical migration and proliferation of junction epithelium in a rat chronic wound model. Alternatively, DUOX-induced ROS stimulated the activation of macrophages and promoted epithelial proliferation in a JNK-dependent manner during Drosophila epithelial disc healing.

Of note, whilst many studies have demonstrated the importance of ROS and macrophage function in other pathologies and physiological contexts, few have specifically investigated this link within wound healing pathophysiology. Importantly, the majority of studies in this area used the oversimplistic M1 and M2 macrophage classifications, whereas in recent years advancements have been made to study the more elaborate classifications of macrophages in the general immunology setting, and this should thus be applied to the macrophages in wound healing setting. Single-cell RNA-sequencing (scRNAseq) and other advanced omics-based techniques have in recent years significantly powered the investigation of the roles of specific cell lineages, including macrophage lineages, in different stages of wound healing,. As such, future investigations seeking to elaborate on the roles of ROS dynamics in wound healing would greatly benefit from the utilisation of these techniques.

ROS and antimicrobial activities

One of the major factors that leads to the formation of chronic wounds is that of prolonged inflammation and pathogenic infection, which can hamper angiogenesis, stem cell function, and extracellular matrix remodelling. During acute wound healing, immune cells are required to eliminate pathogens and prevent infection at the wound site, and ROS play an essential role in this function (Fig. 3). Here, extracellular H2O2 – generated by DUOXs in response to the increased Ca2+ binding following wounding – promotes the production of bacteria-destroying ROS after reacting with halide or thiocyanate,. In the absence of this function, polymicrobial biofilms form, which can lead to the expansion of a pathogenic environment and ultimately the stalling of the wound healing response and thus chronic wound formation.

In a dual action, peroxidases such as myeloperoxidase and eosinophil peroxidase convert H2O2 into other oxidants such as hypochlorous acid, which is then used by neutrophils in antibacterial activities,. This process additionally prevents the toxic build-up of H2O2 which can occur in the early stage of wound healing following leucocyte recruitment, where H2O2 levels are highest,.

Macrophages also play an important role in clearing pathogens during wound healing through phagocytosis. Here, NOX2-derived O2.- is released into phagocytotic vesicles to kill internalised pathogens through respiratory bursts.

ROS in platelet aggregation and angiogenesis

Moderate amounts of ROS (up to a 40% increase) are required for the reduction in platelet adhesion to collagen surfaces and thus platelet activation,. In light of this, and conversely, whilst ROS is known to accelerate platelet function in wound healing, transfer of platelet-derived mitochondria into diabetic mice improved wound healing in part by preventing the overexpression of ROS. Importantly, H2O2 induces the recruitment of vascular smooth muscle cells to the wound site,.

As previously mentioned, NO plays an important role in angiogenesis during wound healing. Here, elevated NO production – as a result of increased activation of NOXs, in particular NOX4 – leads to the stabilisation of HIF-1α and thus promotion of endothelial cell (EC) survival, migration, differentiation, and therefore neovascularisation,–. Highlighting this, near-infrared (NIR)-triggered NO production supressed the proteasomal degradation of HIF-1α. Here, by preventing the interaction of HIF1-α with E3 ubiquitin ligases, both VEGF and CD31 expression was enhanced in ECs, coinciding with increased cell proliferation and migration – collectively accelerating wound healing in diabetic mice. H2O2 produced by NOX4 also activated both the TRPM2, and SERCA2 channels to promote Ca2+ uptake and thus improve EC activity (Fig. 4). In wound healing and other hypoxic-state pathologies such as brain ischemia, these ROS-derived effects on ECs are associated with phosphorylation-dependent activation of various signalling molecules including those of ERK, c-JUN, MAPK, AKT, SMAD, and JNK.

Finally, production of O2·− by both NOX2 and NOX4 also leads to the upregulation of VEGF,. In particular, NOX2 was demonstrated to stimulate VEGFR2 and angiogenesis in wounds through the activation of NF-κB by 2-deoxy-D-ribofuranose 1-phosphate (dRP) – an intermediate of pyrimidine metabolism. This NOX2-derived ROS was primarily generated by both platelets and macrophages,.

H2O2 mediated cell signalling and re-epithelialisation

Many cytoskeletal proteins possess cysteines which are highly sensitive to oxidation, and in a complementary fashion, production of H2O2 occurs primarily in leading edge cells involved in re-epithelialisation. In particular, H2O2 promotes actin cytoskeleton reorganisation and cell migration by directly oxidising actin and actin-binding proteins, as well as activating numerous cell signalling pathways associated with re-epithelialisation.

As discussed previously, there are several mechanisms in which ROS-mediated signalling cascades are initiated in wound healing (Fig. 5). Indeed, ROS production required for both immune cell function and re-epithelialisation share similar stimuli. In one key example, Hunter et al. demonstrated in Drosophila embryo healing that mitochondrially-derived H2O2 – produced downstream of intracellular Ca2+ bursts – led to the polarisation of the actomyosin cytoskeleton and E-cadherin distribution around the wound to promote wound healing. Specifically, this action occurred via oxidation of the Src kinase Src42, and supported results from a previous study in which mitochondrial ROS (mtROS) was produced downstream of Ca2+ bursts following wounding. In addition to Ca2+-mediated activation, DUOX can also be activated downstream of extracellular ATP-activated purinergic receptors–.

One cell signalling pathway regulated by wounding-induced ROS is that of c-JUN. Here, the inhibition of wounding-induced ROS accumulation significantly inhibited healing in planarian worms by preventing F-actin reorganisation and epithelial cell rearrangements – mediated through c-JUN activation at the wound site. Separately, ROS-mediated activation of c-JUN also accelerated wound healing in diabetic rats through increases in angiogenesis and re-epithelialisation, whilst NOX-produced H2O2-activation of the JNK pathway increased epithelial cell proliferation in adult zebrafish tailfin healing.

Alternatively, H2O2 also regulates MAPK signalling during wound healing – namely, through thioredoxin (Trx) oxidation and PI3K/AKT1-Ask1-MAP3K-mediated activation of JNK and p38,,. Interestingly, in a study investigating the interplay between ROS and AKT signalling in Drosophila regeneration, the importance of nutrient sensing and metabolism in this pathway was highlighted. Here, ROS-mediated phosphorylation of Ask1 at Ser38 induced p38-mediated regeneration in a nutrient-sensitive insulin signalling manner, supporting similar findings in studies of stress-induced regeneration in the gut. As metabolic regulation of fibroblasts and keratinocytes during re-epithelialisation is known to be important, future studies should aim to further investigate the role of the MAPK and other relevant signalling pathways.

Another pathway that H2O2 has been shown to be important during the proliferation stage of zebrafish regeneration is that of hedgehog signalling,,. A recent paper using the zebrafish tailfin regeneration model demonstrated that Sonic hedgehog (Shh) – a key signalling protein in the hedgehog signalling cascade – acted downstream of NOX to increase SOD activity and H2O2 production in the early stage of tailfin regeneration, most likely due to SOD oxidation. Interestingly, although not fully elaborated on, the authors also demonstrated binding sites for HIF1α, STAT3, and NF-κB in Shha, suggesting that this kinase may additionally act on these factors to regulate redox balance during wound healing. Importantly, Hedgehog signalling acts in close synergy to canonical Wnt signalling in regeneration as well as other pathological contexts,. In a separate study, NOX-induced H2O2 activated Wnt/β-catenin signalling and induced FGF20 transcriptional activation to promote epidermal regeneration. Canonical Wnt signalling and mitochondrial H2O2 production was also downregulated in a mouse model with TFAM KO, with subsequent defects in epidermal differentiation due to the inhibition of Notch signalling.

As well as its previously mentioned functions during the inflammation stage of wound healing, NF-κB has been shown to play significant roles during re-epithelialisation. Of note, early ROS signalling following embryonic zebrafish tailfin amputation led to the activation of NF-κB as well as promoter activation of vimentin. Here, vimentin promoted collagen formation and organisation. Through serine/tyrosine phosphorylation and ubiquitination, H2O2 acts as a regulator of IκB kinases by inducing their proteolytic degradation,, which subsequently activates NF-κB and therefore promotes angiogenesis and re-epithelialisation. NF-κB is also directly regulated by H2O2-oxidation of cysteine residues in its DNA-binding region. ROS has also been shown to increase the expression of TGF-β1 signalling, with downstream effects including elevated expression of collagen, fibronectin, bFGF, and matrix production,. As mitochondria are important in both TGF-β1 signalling and collagen organisation, as well as that of general ROS regulation during wound healing, future studies should aim to explore the potential link between these factors. Indeed, the link between ROS and TGF-β1-induced epithelial-mesenchymal transition (EMT) has been demonstrated in endometrial cell pathology.

H2O2 was shown to accelerate re-epithelialisation in embryonic zebrafish tailfins following wounding via the Src family kinase (SFK) FYN. Although not confirmed in the particular study, FYN is known to be involved in keratinocyte differentiation,. Of note, this study confirmed findings from other studies whereby wounding led to the activation of Ca2+, ERK, and H2O2-mediated signalling cascades independently of each other.

FOXO are transcription factors important in wound healing, and can either be activated by direct cysteine oxidisation, or in response to upstream redox signalling. In particular, FOXO1 regulates cell cycle progression, apoptosis, and angiogenesis,, and promoted both in vivo and in vitro wound healing by preventing oxidative stress in keratinocytes via the upregulation of GPX-2 and GADD45α – thus maintaining TGF-β1 mediated migration and apoptosis inhibition. Additionally, low level (10 µM) H2O2 treatment induced JNK-mediated FOXO3a translocation and activation to promote AKT-mediated stem cell proliferation, which when transplanted, increased re-epithelialisation and angiogenesis in wounded mice. Here, H2O2 promoted the production of CAT, SOD2, GPX1, and GPX2, collectively increasing stem cell proliferation and preventing oxidative stress.

Nrf2 is a cytoprotective transcription factor which is upregulated in wound healing and acts to restore redox balance by increasing levels of various antioxidants,. In physiological conditions, Nrf2 is ubiquitinated and therefore inactivated by KEAP1. However, oxidation of cysteine residues on KEAP1 – including Cys151, Cys273, and Cys288 – by H2O2 induces a conformational change in KEAP1 and stimulates the activation of Nrf2. Although not studied specifically at the molecular level, the antioxidant activities of Nrf2 play important roles in wound healing – regulating apoptosis, metabolism, autophagy, angiogenesis, as well as cell proliferation and migration. Various studies have attempted to utilise Nrf2-modulating compounds for chronic wound treatment–. However, more research into the specific molecular mechanisms is required in order to further elucidate the specific cellular and molecular role of Nrf2 in wound healing pathophysiology.

Finally, DUOX1-mediated H2O2 production was also shown to be important for peripheral sensory axon reinnervation in zebrafish tailfin wound healing – highlighting another import role that ROS play, even in more uncommonly studied aspects of wound healing.

Interestingly, by comparing ROS expression in both wound healing (early stage, lower levels) and regeneration (later stage, elevated levels) in planarians, Van Huizen et al. demonstrated that different levels of ROS act upstream of signalling pathways in a threshold-dependent manner to dictate the type of response required. Similar results were found when investigating zebrafish, whereby simple wound healing required only early accumulation of ROS for JNK pathway activation, whilst injuries which necessitated new tissue formation required sustained H2O2 production, activating apoptosis pathways as well as JNK,.

Chronic wounds – redox balance abnormalities and current advancements in treatment strategies

A balanced state of oxidative stress is essential for normal wound healing. While physiological levels of ROS are required in the normal transition between wound healing phases, as previously described, an overproduction of ROS has deleterious effects and can hinder wound healing. Multiple molecular mechanisms can explain this effect. For example, healing can be hindered by increased tissue damage, via opposing effects of cytokines such as VEGF and TNFα,. Excessive ROS can also alter and degrade extracellular matrix proteins and impair the function of keratinocytes and fibroblasts.

Diabetic wounds, another category of hard-to-heal wounds, are complex and multifactorial. Their aetiology consists classically of a triad of neuropathy, impaired vascularisation and higher susceptibility to infection. These wounds are also notoriously affected by tissue injury after prolonged hypoxia and excessive oxidative stress. It is thus not surprising that targeting ROS has emerged as a potential therapy for hard-to-heal wounds, similar to other diseases, such as cancer,, neurodegenerative diseases, T cell-mediated autoimmune diseases, inflammatory skin diseases, and others. Specifically regarding cancer, ROS play similar pleiotropic roles as they do in wound healing and chronic wound pathogenesis. Depending on the type of cancer and stage, this can include hypoxia-related ROS functions and signalling pathways such as PI3K/AKT or MAPK/ERK pathways, among others, to promote proliferation, migration, or angiogenesis. Similarly, tight regulation of ROS levels is required for cancer progression and can thus also be potentially targeted therapeutically.

Another factor to take into account is that of senescence, which is the phenomenon of cell cycle arrest and the inhibition of cell proliferation, and is a hallmark of several age-related pathologies, including in the pathogenesis of some chronic wounds. ROS accumulation and oxidative stress can accelerate senescence in both fibroblasts and endothelial cells, whilst UV-induced ROS upregulation additionally increases senescence and photoageing in skin.

Diverse strategies have emerged to modulate ROS in wound healing, namely the use of antioxidant materials such as N-acetyl-l-cysteine (NAC) or enzymes which either increase local perfusion such as glucose oxidase, or clear free radicals through SODs,. Biocompounds that target ROS have also been implicated in improved wound healing, mediated by their effects on perfusion, cell migration, and ROS suppression. Examples of these molecules are Resolvin E1, PDGF, Galectin-1, Alpha-arbutin and Nicotinamide–. Nanoparticles have also been developed to improve wound healing, mainly via ROS scavenging, anti-inflammatory and antibacterial effects, and applied to several in vitro and in vivo models–, as well as other molecules–.

On the other hand, increased angiogenesis has been demonstrated when wounds were treated topically with H2O2 and both hyperbaric and topical oxygen led to accelerated wound healing–. The array of both pro- and anti-ROS treatment stratagies that have been applied to the study of wound healing are described in detail in Table 1.

There is, however, a lack of understanding of the exact underlying mechanisms behind the effect of these molecules in many studies and a lack of validation in human samples, which may explain the scarcity of clinical translation. It is also not always evident in the course of a chronic wound history when there is a need to reduce or stimulate ROS production, hence the importance of allying possible treatment strategies that target ROS with the use of sensors that could translate the actual needs of the wound at that given moment. The utilisation of omics approaches such as scRNAseq to delineate the specific effects of ROS modulation in individual cell types during different stages of wound healing and chronic wound pathogenesis would additionally be of benefit for this purpose.

Conclusions and perspective

ROS and their essential roles in cellular signalling regulation is one of the most important components of the complex pathophysiology of the wound healing cascade. However, owing to the multifaceted nature of wound healing and chronic wound formation, improper regulation of either ROS production or removal can lead to oxidative stress and impairment of wound healing, contributing to the formation and propagation of chronic wounds. In light of this, there has been a greater emphasis in recent years towards investigating whether ROS can be targeted to either accelerate wound healing, or conversely, be used as a treatment for chronic wounds – with no concrete advancements with regards to clinically approved therapies as of yet.

This discrepancy can partially be explained by gaps in knowledge surrounding the cellular and molecular landscape of ROS in wound healing, including for example, the role of ROS and metabolism,, as well as that of redox signalling and stem cell homeostasis. In addition, future work is required in order to elucidate the specific dynamics of ROS and in particular H2O2, including the movement of H2O2 and its interplay with specific AQPs and gap junctions, or the role of ROS and other ROS-producing organelles such as the ER, which play important roles in wound healing and may potentially be targeted through pre-clinical agents.

Finally, it is important to note that whilst most of the investigations into the role of ROS in wound healing have been performed in animal models such as zebrafish or Drosophila, these studies have predominantly investigated the similar but pathophysiologically different process of regeneration, as opposed to wound healing itself. However, the fact that various studies have shown that many of these pathways are activated in separate animal models,, – such as ERK signalling – suggests that the effects of ROS are phylogenetically conserved. However, advances in methods which allow for more targeted analyses of specific cell types and their roles in different stage of wound healing pathophysiology, such as scRNAseq, are an important step in advancing knowledge in the field of ROS and wound healing.

References 199

  1. 1.

    Peña, O. & Martin, P. Cellular and molecular mechanisms of skin wound healing. Nat. Rev. Mol. Cell Biol. 25, 599–616 (2024).

    Not in our library10.1038/s41580-024-00715-1

  2. 2.

    Torres, M. et al. The temporal dynamics of proteins in aged skin wound healing and comparison to gene expression. J. Invest. Dermatol. (2024).

    Not in our library10.1016/j.jid.2024.09.024

  3. 3.

    Schultz, G. et al. In Principles of Wound Healing. (University of Adelaide Press, 2011).

    Not in our library

  4. 4.

    Eming S, Krieg T, Davidson J. Inflammation in wound repair: molecular and cellular mechanisms. J. Invest. Dermatol. 2007;127:514-525.

    Not in our library10.1038/sj.jid.5700701

  5. 5.
    Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes · 2023
    No notice
  6. 6.

    Evans J, Kaitu’u-Lino T, Salamonsen L. Extracellular matrix dynamics in scar-free endometrial repair: perspectives from mouse in vivo and human in vitro studies. Biol. Reprod. 2011;85:511-523.

    Not in our library10.1095/biolreprod.111.090993

  7. 7.

    Dunnill C, et al. Reactive oxygen species (ROS) and wound healing: The functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process. Int. Wound J. 2017;14:89-96.

    Not in our library10.1111/iwj.12557

  8. 8.

    Sies H, Jones D. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21:363-383.

    Not in our library10.1038/s41580-020-0230-3

  9. 9.

    Polaka S, Katare P, Pawar B. & et, a. Emerging ROS-modulating technologies for augmentation of the wound healing process. ACS Omega. 2022;7:30657-30672.

    Not in our library10.1021/acsomega.2c02675

  10. 10.

    Schieber M, Chandel N. ROS function in redox signaling and oxidative stress. Curr. Biol. 2014;24:R453-R462.

    Not in our library10.1016/j.cub.2014.03.034

  11. 11.

    Klyubin I, et al. Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils. Eur. J. Cell Biol. 1996;70:347-351.

    Not in our library

  12. 12.

    Li X, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Exp. Mol. Med. 2018;50:1-14.

    Not in our library10.1038/s12276-018-0058-5

  13. 13.

    Vara D, et al. Direct Activation of NADPH Oxidase 2 by 2-Deoxyribose-1-Phosphate Triggers Nuclear Factor Kappa B-Dependent Angiogenesis. Antioxid. Redox Signal. 2018;28:110-130.

    Not in our library10.1089/ars.2016.6869

  14. 14.

    Wang, G. et al. The initiation of oxidative stress and therapeutic strategies in wound healing. Biomed. Pharmacother.157, 114004 (2023).

    Not in our library10.1016/j.biopha.2022.114004

  15. 15.
    Targeting Oxidative Stress and Mitochondrial Dysfunction in the Treatment of Impaired Wound Healing: A Systematic Review · 2018
    No notice
  16. 16.

    Yoo S, Starnes T, Deng Q, Huttenlocher A. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature. 2011;480:109-112.

    Not in our library10.1038/nature10632

  17. 17.

    Niethammer P, Grabher C, Look A, Mitchison T. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature. 2009;459:996-999.

    Not in our library10.1038/nature08119

  18. 18.

    Love, N. et al. Amputation-induced reactive oxygen species are required for successful Xenopus tadpole tail regeneration. Nat. Cell Biol.15, 222–228 (2013).

    Not in our library10.1038/ncb2659

  19. 19.

    Gauron, C. et al. Sustained production of ROS triggers compensatory proliferation and is required for regeneration to proceed. Sci. Rep.3, 2084 (2013).

    Not in our library10.1038/srep02084

  20. 20.

    Al Haj Baddar N, Chithrala A, Voss S. Amputation-induced reactive oxygen species signaling is required for axolotl tail regeneration. Dev. Dyn. 2019;248:189-196.

    Not in our library10.1002/dvdy.5

  21. 21.

    Labit, E. et al. Opioids prevent regeneration in adult mammals through inhibition of ROS production. Sci. Rep.8, 12170 (2018).

    Not in our library10.1038/s41598-018-29594-1

  22. 22.

    Santabárbara-Ruiz P, et al. Ask1 and Akt act synergistically to promote ROS-dependent regeneration in Drosophila. PLoS Genet. 2019;15:e1007926.

    Not in our library10.1371/journal.pgen.1007926

  23. 23.

    Gouzos M, et al. Antibiotics Affect ROS Production and Fibroblast Migration in an In-vitro Model of Sinonasal Wound Healing. Front. Cell Infect. Microbiol. 2020;10:110.

    Not in our library10.3389/fcimb.2020.00110

  24. 24.

    Xu, Z., Han, S., Gu, Z. & Wu, J. Advances and Impact of Antioxidant Hydrogel in Chronic Wound Healing. Adv. Healthc. Mater.9, e1901502 (2020).

    Not in our library10.1002/adhm.201901502

  25. 25.
    ROS-scavenging materials for skin wound healing: advancements and applications · 2023
    No notice
  26. 26.

    Checa J, Aran J. Reactive Oxygen Species: Drivers of Physiological and Pathological Processes. J. Inflamm. Res. 2020;13:1057-1073.

    Not in our library10.2147/jir.s275595

  27. 27.
    The Role of Hydrogen Peroxide in Redox-Dependent Signaling: Homeostatic and Pathological Responses in Mammalian Cells · 2018
    No notice
  28. 28.

    Santos C, Hafstad A, Beretta M. & al., e. Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signaling. EMBO J. 2016;35:319-334.

    Not in our library10.15252/embj.201592394

  29. 29.

    Bienert G, Schjoerring J, Jahn T. Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta. 2006;1758:994-1003.

    Not in our library10.1016/j.bbamem.2006.02.015

  30. 30.

    Henzler T, Steudle E. Transport and metabolic degradation of hydrogen peroxide in Chara corallina: model calculations and measurements with the pressure probe suggest transport of H(2)O(2) across water channels. J. Exp. Bot. 2000;51:2053-2066.

    Not in our library10.1093/jexbot/51.353.2053

  31. 31.

    García-Dorado D, Rodríguez-Sinovas A, Ruiz-Meana M. Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Cardiovasc Res. 2004;61:386-401.

    Not in our library10.1016/j.cardiores.2003.11.039

  32. 32.

    Kaya A, Lee B, Gladyshev V. Regulation of protein function by reversible methionine oxidation and the role of selenoprotein MsrB1. Antioxid. Redox Signal. 2015;23:814-822.

    Not in our library10.1089/ars.2015.6385

  33. 33.

    Sun, X. et al. The Natural Diterpenoid Isoforretin A Inhibits Thioredoxin-1 and Triggers Potent ROS-Mediated Antitumor Effects. Cancer Res.77, 926–936 (2017).

    Not in our library10.1158/0008-5472.can-16-0987

  34. 34.

    Holmström K, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 2014;15:411-421.

    Not in our library10.1038/nrm3801

  35. 35.

    Dickinson B, Chang C. Chemistry and biology of reactive oxygen species in signaling or stress responses. Nat. Chem. Biol. 2011;7:504-511.

    Not in our library10.1038/nchembio.607

  36. 36.

    Bedard K, Krause K. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007;87:245-313.

    Not in our library10.1152/physrev.00044.2005

  37. 37.

    Parascandolo A, Laukkanen M. Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways. Antioxid. Redox Signal. 2019;30:443-486.

    Not in our library10.1089/ars.2017.7268

  38. 38.

    Yoshihara A, et al. Regulation of dual oxidase expression and H2O2 production by thyroglobulin. Thyroid. 2012;22:1054-1062.

    Not in our library10.1089/thy.2012.0003

  39. 39.

    Murphy M. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1-13.

    Not in our library10.1042/bj20081386

  40. 40.

    Boveris A, Oshino N, Chance B. The cellular production of hydrogen peroxide. Biochem. J. 1972;128:617-630.

    Not in our library10.1042/bj1280617

  41. 41.

    Hunt, M., Torres, M., Bachar-Wikström, E. & Wikström, J. Multifaceted roles of mitochondria in wound healing and chronic wound pathogenesis. Front. Cell Dev. Biol.11, 1252318 (2023).

    Not in our library10.3389/fcell.2023.1252318

  42. 42.

    Wong H, Benoit B, Brand M. Mitochondrial and cytosolic sources of hydrogen peroxide in resting C2C12 myoblasts. Free Radic. Biol. Med. 2019;130:140-150.

    Not in our library10.1016/j.freeradbiomed.2018.10.448

  43. 43.

    Niedzwiecki M, et al. The Exposome: Molecules to Populations. Annu Rev. Pharm. Toxicol. 2019;59:107-127.

    Not in our library10.1146/annurev-pharmtox-010818-021315

  44. 44.

    Rada B, Leto T. Oxidative innate immune defenses by Nox/Duox Family NADPH oxidases. Contrib. Microbiol. 2008;15:164-187.

    Not in our library10.1159/000136357

  45. 45.

    Martínez-Revelles S, et al. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid. Redox Signal. 2013;18:51-65.

    Not in our library10.1089/ars.2011.4335

  46. 46.
    Peroxisomal β-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis · 2021
    No notice
  47. 47.

    Rhee S, Kil I. Multiple Functions and Regulation of Mammalian Peroxiredoxins. Annu. Rev. Biochem. 2017;86:749-775.

    Not in our library10.1146/annurev-biochem-060815-014431

  48. 48.

    Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979;59:527-605.

    Not in our library10.1152/physrev.1979.59.3.527

  49. 49.

    Brigelius-Flohé R, Flohé L. Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxid. Redox Signal. 2020;33:498-516.

    Not in our library10.1089/ars.2019.7905

  50. 50.

    Rampon, C., Volovitch, M., Joliot, A. & Vriz, S. Hydrogen Peroxide and Redox Regulation of Developments. Antioxidants7, 159 (2018).

    Not in our library10.3390/antiox7110159

  51. 51.

    Ronchi J, Francisco A, Passos L, Figueira T, Castilho R. The Contribution of Nicotinamide Nucleotide Transhydrogenase to Peroxide Detoxification Is Dependent on the Respiratory State and Counterbalanced by Other Sources of NADPH in Liver Mitochondria. J. Biol. Chem. 2016;291:20173-20187.

    Not in our library10.1074/jbc.m116.730473

  52. 52.

    Hong W, et al. The Role of Hypoxia-Inducible Factor in Wound Healing. Adv. Wound Care. 2014;3:390-399.

    Not in our library10.1089/wound.2013.0520

  53. 53.

    Fujiwara T, et al. Extracellular superoxide dismutase deficiency impairs wound healing in advanced age by reducing neovascularization and fibroblast function. Exp. Dermatol. 2016;25:206-211.

    Not in our library10.1111/exd.12909

  54. 54.

    Akhigbe, R. & Ajayi, A. The impact of reactive oxygen species in the development of cardiometabolic disorders: a review. Lipids Health Dis.20, 23 (2021).

    Not in our library10.1186/s12944-021-01435-7

  55. 55.

    Madreiter-Sokolowski, C., Thomas, C. & Ristow, M. Interrelation between ROS and Ca 2+ in aging and age-related diseases. Redox Biol. 36, 101678 (2020).

    Not in our library10.1016/j.redox.2020.101678

  56. 56.

    Schapira A, et al. Mitochondrial complex I deficiency in Parkinson’s disease. J. Neurochem. 1990;54:823-827.

    Not in our library10.1111/j.1471-4159.1990.tb02325.x

  57. 57.

    Hasani, M. et al. Oxidative balance score and risk of cancer: a systematic review and meta-analysis of observational studies. BMC Cancer23, 1143 (2023).

    Not in our library10.1186/s12885-023-11657-w

  58. 58.

    Wlaschek M, Singh K, Sindrilaru A, Crisan D, Scharffetter-Kochanek K. Iron and iron-dependent reactive oxygen species in the regulation of macrophages and fibroblasts in non-healing chronic wounds. Free Radic. Biol. Med. 2019;133:262-275.

    Not in our library10.1016/j.freeradbiomed.2018.09.036

  59. 59.

    Sivaraj, D. et al. Nitric oxide-releasing gel accelerates healing in a diabetic murine splinted excisional wound model. Front. Med.10, 1060758 (2023).

    Not in our library10.3389/fmed.2023.1060758

  60. 60.

    Papapetropoulos A, García-Cardeña G, Madri J, Sessa W. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 1997;100:3131-3139.

    Not in our library10.1172/jci119868

  61. 61.

    Paul-Clark M, Gilroy D, Willis D, Willoughby D, Tomlinson A. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. J. Immunol. 2001;166:1169-1177.

    Not in our library10.4049/jimmunol.166.2.1169

  62. 62.

    Donnini S, Ziche M. Constitutive and inducible nitric oxide synthase: role in angiogenesis. Antioxid. Redox Signal. 2002;4:817-823.

    Not in our library10.1089/152308602760598972

  63. 63.

    Kitano T, et al. Impaired Healing of a Cutaneous Wound in an Inducible Nitric Oxide Synthase-Knockout Mouse. Dermatol. Res. Pr. 2017;2017:2184040.

    Not in our library10.1155/2017/2184040

  64. 64.

    Yang, Y. et al. Ubiquitination Flow Repressors: Enhancing Wound Healing of Infectious Diabetic Ulcers through Stabilization of Polyubiquitinated Hypoxia-Inducible Factor-1α by Theranostic Nitric Oxide Nanogenerators. Adv. Mater.33, 2103593 (2021).

    Not in our library10.1002/adma.202103593

  65. 65.

    Lin, Y. et al. In Situ Self-Assembling Micellar Depots that Can Actively Trap and Passively Release NO with Long-Lasting Activity to Reverse Osteoporosis. Adv. Mater. 30, e1705605 (2018).

    Not in our library10.1002/adma.201705605

  66. 66.

    Radziwon-Balicka A, et al. Differential eNOS-signalling by platelet subpopulations regulates adhesion and aggregation. Cardiovasc Res. 2017;113:1719-1731.

    Not in our library10.1093/cvr/cvx179

  67. 67.

    Arany I, Brysk M, Brysk H, Tyring S. Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes. Biochem. Biophys. Res. Commun. 1996;220:618-622.

    Not in our library10.1006/bbrc.1996.0452

  68. 68.

    Krischel V, et al. Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J. Invest. Dermatol. 1998;111:286-291.

    Not in our library10.1046/j.1523-1747.1998.00268.x

  69. 69.

    Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J, Frank S. The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J. Invest. Dermatol. 1999;113:1090-1098.

    Not in our library10.1046/j.1523-1747.1999.00784.x

  70. 70.

    Malone-Povolny M, Maloney S, Schoenfisch M. Nitric Oxide Therapy for Diabetic Wound Healing. Adv. Health. Mater. 2019;8:e1801210.

    Not in our library10.1002/adhm.201801210

  71. 71.

    Peters S, Mathy M, Pfaffendorf M, van Zwieten P. Reactive oxygen species-induced aortic vasoconstriction and deterioration of functional integrity. Naunyn Schmiedebergs Arch. Pharm. 2000;361:127-133.

    Not in our library10.1007/s002109900148

  72. 72.
    Calcium Flashes Orchestrate the Wound Inflammatory Response through DUOX Activation and Hydrogen Peroxide Release · 2013
    No notice
  73. 73.

    de Oliveira S, et al. ATP modulates acute inflammation in vivo through dual oxidase 1-derived H2O2 production and NF-κB activation. J. Immunol. 2014;192:5710-5719.

    Not in our library10.4049/jimmunol.1302902

  74. 74.

    Eming S, Wynn T, Martin P. Inflammation and metabolism in tissue repair and regeneration. Science. 2017;56:1026-1030.

    Not in our library10.1126/science.aam7928

  75. 75.

    Weinberg S, Sena L, Chandel N. Mitochondria in the regulation of innate and adaptive immunity. Immunity. 2015;42:406-417.

    Not in our library10.1016/j.immuni.2015.02.002

  76. 76.

    Willenborg, S. et al. Mitochondrial metabolism coordinates stage-specific repair processes in macrophages during wound healing. Cell Metab.33, 2398–2414.e9 (2020).

    Not in our library10.1016/j.cmet.2021.10.004

  77. 77.

    Lee C, Qiao M, Schröder K, Zhao Q, Asmis R. Nox4 is a novel inducible source of reactive oxygen species in monocytes and macrophages and mediates oxidized low density lipoprotein-induced macrophage death. Circ. Res. 2010;106:1489-1497.

    Not in our library10.1161/circresaha.109.215392

  78. 78.

    Kim S, Nair M. Macrophages in wound healing: activation and plasticity. Immunol. Cell Biol. 2019;97:258-267.

    Not in our library10.1111/imcb.12236

  79. 79.

    Bulua A, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J. Exp. Med. 2011;208:519-533.

    Not in our library10.1084/jem.20102049

  80. 80.

    Zhao C, Gillette D, Li X, Zhang Z, Wen H. Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation. J. Biol. Chem. 2014;289:17020-17029.

    Not in our library10.1074/jbc.m114.563114

  81. 81.

    Cuadrado A, et al. Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharm. Rev. 2018;70:348-383.

    Not in our library10.1124/pr.117.014753

  82. 82.

    Bonello S, et al. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb. Vasc. Biol. 2007;27:755-761.

    Not in our library10.1161/01.atv.0000258979.92828.bc

  83. 83.

    Ranneh Y, et al. Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review. Appl Biol. Chem. 2017;60:327-338.

    Not in our library10.1007/s13765-017-0285-9

  84. 84.

    Villarino, A., Kanno, Y. & O’Shea, J. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat. Immunol., 18, 374-384 (2017).

    Not in our library10.1038/ni.3691

  85. 85.
    Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action · 2021
    Not checked
  86. 86.

    Bhattacharjee A, et al. IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages. Free Radic. Biol. Med. 2013;54:1-16.

    Not in our library10.1016/j.freeradbiomed.2012.10.553

  87. 87.

    Ekuni D, et al. Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model. Am. J. Pathol. 2009;175:1398-1409.

    Not in our library10.2353/ajpath.2009.090108

  88. 88.

    Fogarty C, et al. Extracellular Reactive Oxygen Species Drive Apoptosis-Induced Proliferation via Drosophila Macrophages. Curr. Biol. 2016;26:575-584.

    Not in our library10.1016/j.cub.2015.12.064

  89. 89.
    Reactive Oxygen Species in Macrophages: Sources and Targets · 2021
    No notice
  90. 90.

    Bian Z, et al. Deciphering human macrophage development at single-cell resolution. Nature. 2020;582:571-576.

    Not in our library10.1038/s41586-020-2316-7

  91. 91.

    Zheng H, et al. Recent advances in strategies to target the behavior of macrophages in wound healing. Biomed. Pharmacother. 2023;165:115199.

    Not in our library10.1016/j.biopha.2023.115199

  92. 92.

    Xiao Y, et al. Single-cell profiling and functional screening reveal crucial roles for lncRNAs in the epidermal re-epithelialization of human acute wounds. Front. Surg. 2024;11:1349135.

    Not in our library10.3389/fsurg.2024.1349135

  93. 93.

    Falanga V, et al. Chronic wounds. Nat. Rev. Dis. Prim. 2022;8:50.

    Not in our library10.1038/s41572-022-00377-3

  94. 94.

    Clark R. Basics of cutaneous wound repair. J. Dermatol Surg. Oncol. 1993;19:693-706.

    Not in our library10.1111/j.1524-4725.1993.tb00413.x

  95. 95.

    Geiszt M, Witta J, Baffi J, Lekstrom K, Leto T. Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. FASEB J. 2003;17:1502-1504.

    Not in our library10.1096/fj.02-1104fje

  96. 96.

    Ha E, Oh C, Bae Y, Lee W. A direct role for dual oxidase in Drosophila gut immunity. Science. 2005;310:847-850.

    Not in our library10.1126/science.1117311

  97. 97.

    Cavallo, I. et al. Homocysteine and Inflammatory Cytokines in the Clinical Assessment of Infection in Venous Leg Ulcers. Antibiotics11, 1268 (2022).

    Not in our library10.3390/antibiotics11091268

  98. 98.

    Winterbourn C, Kettle A, Hampton M. Reactive Oxygen Species and Neutrophil Function. Annu. Rev. Biochem. 2016;85:765-792.

    Not in our library10.1146/annurev-biochem-060815-014442

  99. 99.
    Diverse stimuli engage different neutrophil extracellular trap pathways · 2017
    No notice
  100. 100.

    Pase L, Nowell C, Lieschke G. In vivo real-time visualization of leukocytes and intracellular hydrogen peroxide levels during a zebrafish acute inflammation assay. Methods Enzymol. 2012;506:135-156.

    Not in our library10.1016/b978-0-12-391856-7.00032-9

  101. 101.

    Ojha N, et al. Assessment of wound-site redox environment and the significance of Rac2 in cutaneous healing. Free Radic. Biol. Med. 2008;44:682-691.

    Not in our library10.1016/j.freeradbiomed.2007.10.056

  102. 102.

    Méndez D, et al. Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels. Int. J. Mol. Sci. 2020;21:6192.

    Not in our library10.3390/ijms21176192

  103. 103.

    Fidler T, et al. Superoxide Dismutase 2 is dispensable for platelet function. Thromb. Haemost. 2017;117:1859-1867.

    Not in our library10.1160/th17-03-0174

  104. 104.

    Kim, S. et al. Platelet-derived mitochondria transfer facilitates wound-closure by modulating ROS levels in dermal fibroblasts. Platelets34, 2151996 (2022).

    Not in our library10.1080/09537104.2022.2151996

  105. 105.

    Li W, Liu G, Chou I, Kagan H. Hydrogen peroxide-mediated, lysyl oxidase-dependent chemotaxis of vascular smooth muscle cells. J. Cell Biochem. 2000;78:550-557.

    Not in our library10.1002/1097-4644(20000915)78:4<550::aid-jcb4>3.0.co;2-8

  106. 106.

    Brüne B. Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ. 2003;10:864-869.

    Not in our library10.1038/sj.cdd.4401261

  107. 107.

    Cai Z, et al. Endothelial Nitric Oxide Synthase-Derived Nitric Oxide Prevents Dihydrofolate Reductase Degradation via Promoting S-Nitrosylation. Arterioscler Thromb. Vasc. Biol. 2015;35:2366-2373.

    Not in our library10.1161/atvbaha.115.305796

  108. 108.

    Wang J, Hong Z, Zeng C, Yu Q, Wang H. NADPH oxidase 4 promotes cardiac microvascular angiogenesis after hypoxia/reoxygenation in vitro Free. Radic. Biol. Med. 2014;69:278-288.

    Not in our library10.1016/j.freeradbiomed.2014.01.027

  109. 109.

    Martinotti, S., Patrone, M., Balbo, V., Mazzucco, L. & Ranzato, E. Endothelial response boosted by platelet lysate: the involvement of calcium toolkit. Int. J. Mol. Sci. 21, 808 (2020).

    Not in our library10.3390/ijms21030808

  110. 110.

    Evangelista A, Thompson M, Bolotina V, Tong X, Cohen R. Nox4- and Nox2-dependent oxidant production is required for VEGF-induced SERCA cysteine-674 S-glutathiolation and endothelial cell migration. Free Radic. Biol. Med. 2012;53:2327-2334.

    Not in our library10.1016/j.freeradbiomed.2012.10.546

  111. 111.

    Yang J. The role of reactive oxygen species in angiogenesis and preventing tissue injury after brain ischemia. Microvasc. Res. 2019;123:62-67.

    Not in our library10.1016/j.mvr.2018.12.005

  112. 112.

    Menden H, Welak S, Cossette S, Ramchandran R, Sampath V. Lipopolysaccharide (LPS)-mediated angiopoietin-2-dependent autocrine angiogenesis is regulated by NADPH oxidase 2 (Nox2) in human pulmonary microvascular endothelial cells. J. Biol. Chem. 2015;290:5449-5461.

    Not in our library10.1074/jbc.m114.600692

  113. 113.

    Brown N, Bicknell R. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. Biochem J. 1998;334:1-8.

    Not in our library10.1042/bj3340001

  114. 114.
    The Redox Proteome · 2013
    No notice
  115. 115.

    Pak V, et al. Ultrasensitive Genetically Encoded Indicator for Hydrogen Peroxide Identifies Roles for the Oxidant in Cell Migration and Mitochondrial Function. Cell Metab. 2020;31:642-653.e646.

    Not in our library10.1016/j.cmet.2020.02.003

  116. 116.

    Balta E, Kramer J, Samstag Y. Redox Regulation of the Actin Cytoskeleton in Cell Migration and Adhesion: On the Way to a Spatiotemporal View. Front. Cell Dev. Biol. 2021;8:618261.

    Not in our library10.3389/fcell.2020.618261

  117. 117.

    Hunter M, Willoughby P, AEE B, Fernandez-Gonzalez R. Oxidative Stress Orchestrates Cell Polarity to Promote Embryonic Wound Healing. Dev. Cell. 2018;47:377-387.

    Not in our library10.1016/j.devcel.2018.10.013

  118. 118.

    Xu S, Chisholm AC. elegans epidermal wounding induces a mitochondrial ROS burst that promotes wound repair. Dev. Cell. 2014;31:48-60.

    Not in our library10.1016/j.devcel.2014.08.002

  119. 119.

    Sherwood C, Lantz R, Burgess J, Boitano S. Arsenic alters ATP-dependent Ca²+ signaling in human airway epithelial cell wound response. Toxicol. Sci. 2011;121:191-206.

    Not in our library10.1093/toxsci/kfr044

  120. 120.

    Bucheimer R, Linden J. Purinergic regulation of epithelial transport. J. Physiol. 2004;555:311-321.

    Not in our library10.1113/jphysiol.2003.056697

  121. 121.

    Pillai S, Bikle D. Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium, and inhibits terminal differentiation of human epidermal keratinocytes. J. Clin. Invest. 1992;90:42-51.

    Not in our library10.1172/jci115854

  122. 122.

    Van Huizen, A., Hack, S., Greene, J., Kinsey, L. & Beane, W. Reactive Oxygen Species Signaling Differentially Controls Wound Healing and Regeneration. bioRxiv, https://www.biorxiv.org/content/10.1101/2022.04.05.487111v1.full (2022).

    Not in our library

  123. 123.

    Yue, C. et al. c-Jun Overexpression Accelerates Wound Healing in Diabetic Rats by Human Umbilical Cord-Derived Mesenchymal Stem Cells. Stem Cells Int.2020, 7430968 (2020).

    Not in our library10.1155/2020/7430968

  124. 124.

    Fujino G, et al. Thioredoxin and TRAF family proteins regulate reactive oxygen species-dependent activation of ASK1 through reciprocal modulation of the N-terminal homophilic interaction of ASK1. Mol. Cell Biol. 2007;27:8152-8163.

    Not in our library10.1128/mcb.00227-07

  125. 125.

    Esteban-Collado, J., Corominas, M. & Serras, F. Nutrition and PI3K/Akt signaling are required for p38-dependent regeneration. Development148, dev197087 (2021).

    Not in our library10.1242/dev.197087

  126. 126.

    Patel P, et al. Damage sensing by a Nox-Ask1-MKK3-p38 signaling pathway mediates regeneration in the adult Drosophila midgut. Nat. Commun. 2019;10:4365.

    Not in our library10.1038/s41467-019-12336-w

  127. 127.

    Manchanda M, et al. Metabolic Reprogramming and Reliance in Human Skin Wound Healing. J. Invest Dermatol. 2023;S0022-202X:01975-01979.

    Not in our library10.1016/j.jid.2023.02.039

  128. 128.

    Romero M, McCathie G, Jankun P, Roehl H. Damage-induced reactive oxygen species enable zebrafish tail regeneration by repositioning of Hedgehog expressing cells. Nat. Commun. 2018;9:4010.

    Not in our library10.1038/s41467-018-06460-2

  129. 129.

    Meda F, et al. Nerves Control Redox Levels in Mature Tissues Through Schwann Cells and Hedgehog Signaling. Antioxid. Redox Signal. 2016;24:299-311.

    Not in our library10.1089/ars.2015.6380

  130. 130.

    Thauvin M, et al. An early Shh-H2O2 reciprocal regulatory interaction controls the regenerative program during zebrafish fin regeneration. J. Cell Sci. 2022;135:jcs259664.

    Not in our library10.1242/jcs.259664

  131. 131.

    Singh B, Doyle M, Weaver C, Koyano-Nakagawa N, Garry D. Hedgehog and Wnt coordinate signaling in myogenic progenitors and regulate limb regeneration. Dev. Biol. 2012;371:23-34.

    Not in our library10.1016/j.ydbio.2012.07.033

  132. 132.

    Hamanaka, R. et al. Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci Signal6, ra8 (2013).

    Not in our library10.1126/scisignal.2003638

  133. 133.
    Damage-induced reactive oxygen species regulate vimentin and dynamic collagen-based projections to mediate wound repair · 2018
    Not checked
  134. 134.

    Morgan M, Liu Z. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 2011;21:103-115.

    Not in our library10.1038/cr.2010.178

  135. 135.

    Kamata H, Manabe T, Oka S, Kamata K, Hirata H. Hydrogen peroxide activates IkappaB kinases through phosphorylation of serine residues in the activation loops. FEBS Lett. 2002;519:231-237.

    Not in our library10.1016/s0014-5793(02)02712-6

  136. 136.

    Halvey P, et al. Selective oxidative stress in cell nuclei by nuclear-targeted D-amino acid oxidase. Antioxid. Redox Signal. 2007;9:807-816.

    Not in our library10.1089/ars.2007.1526

  137. 137.

    Schwörer S, et al. Proline biosynthesis is a vent for TGFβ-induced mitochondrial redox stress. EMBO J. 2020;39:e103334.

    Not in our library10.15252/embj.2019103334

  138. 138.

    Bansal R, et al. Role of the mitochondrial protein cyclophilin D in skin wound healing and collagen secretion. JCI Insight. 2024;9:e169213.

    Not in our library10.1172/jci.insight.169213

  139. 139.

    Zhao F, Wei W, Huang D, Guo Y. Knockdown of miR-27a reduces TGFβ-induced EMT and H 2 O 2 -induced oxidative stress through regulating mitochondrial autophagy. Am. J. Transl. Res. 2023;15:6071-6082.

    Not in our library

  140. 140.

    Yoo S, Freisinger C, LeBert D, Huttenlocher A. Early redox, Src family kinase, and calcium signaling integrate wound responses and tissue regeneration in zebrafish. J. Cell Biol. 2012;199:225-234.

    Not in our library10.1083/jcb.201203154

  141. 141.

    Cabodi S, et al. A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. Mol. Cell. 2000;6:1121-1129.

    Not in our library10.1016/s1097-2765(00)00110-6

  142. 142.

    Saito Y, Jensen A, Salgia R, Posadas E. Fyn: a novel molecular target in cancer. Cancer. 2010;116:1629-1637.

    Not in our library10.1002/cncr.24879

  143. 143.
    Cellular adaptation to xenobiotics: Interplay between xenosensors, reactive oxygen species and FOXO transcription factors · 2017
    No notice
  144. 144.

    Miao C, Li Y, Zhang X. The functions of FoxO transcription factors in epithelial wound healing. Australas. J. Dermatol. 2019;60:105-109.

    Not in our library10.1111/ajd.12952

  145. 145.

    Jeon H, et al. FOXO1 regulates VEGFA expression and promotes angiogenesis in healing wounds. J. Pathol. 2018;245:258-264.

    Not in our library10.1002/path.5075

  146. 146.

    Ponugoti B, et al. FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress. J. Cell Biol. 2013;203:327-343.

    Not in our library10.1083/jcb.201305074

  147. 147.

    Dhoke N, Geesala R, Das A. Low Oxidative Stress-Mediated Proliferation Via JNK-FOXO3a-Catalase Signaling in Transplanted Adult Stem Cells Promotes Wound Tissue Regeneration. Antioxid. Redox Signal. 2018;28:1047-1065.

    Not in our library10.1089/ars.2016.6974

  148. 148.
    Transcriptional Regulation by Nrf2 · 2018
    No notice
  149. 149.

    Schmidt, A. & Bekeschus, S. Redox for Repair: Cold Physical Plasmas and Nrf2 Signaling Promoting Wound Healing. Antioxidants7, 146 (2018).

    Not in our library10.3390/antiox7100146

  150. 150.

    Fourquet S, Guerois R, Biard D, Toledano M. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J. Biol. Chem. 2010;285:8463-8471.

    Not in our library10.1074/jbc.m109.051714

  151. 151.

    Süntar I, et al. Regulatory Role of Nrf2 Signaling Pathway in Wound Healing Process. Molecules. 2021;26:2424.

    Not in our library10.3390/molecules26092424

  152. 152.

    Long M, et al. An Essential Role of NRF2 in Diabetic Wound Healing. Diabetes. 2016;65:780-793.

    Not in our library10.2337/db15-0564

  153. 153.

    Kuhn J, et al. Nrf2-activating Therapy Accelerates Wound Healing in a Model of Cutaneous Chronic Venous Insufficiency. Plast. Reconstr. Surg. Glob. Open. 2020;8:e3006.

    Not in our library10.1097/gox.0000000000003006

  154. 154.

    Li, D. et al. LPS-stimulated Macrophage Exosomes Inhibit Inflammation by Activating the Nrf2 / HO-1 Defense Pathway and Promote Wound Healing in Diabetic Rats, 2020, PREPRINT. Res. Sq. Preprint at: 10.21203/rs.3.rs-78864/v1 (2020).

    Not in our library

  155. 155.

    Fan J, et al. Procyanidin B2 improves endothelial progenitor cell function and promotes wound healing in diabetic mice via activating Nrf2. J. Cell Mol. Med. 2021;25:652-665.

    Not in our library10.1111/jcmm.16111

  156. 156.
    Nrf2 Suppression Delays Diabetic Wound Healing Through Sustained Oxidative Stress and Inflammation · 2019
    No notice
  157. 157.

    Hozzein W, et al. Bee venom improves diabetic wound healing by protecting functional macrophages from apoptosis and enhancing Nrf2, Ang-1 and Tie-2 signaling. Mol. Immunol. 2018;103:322-335.

    Not in our library10.1016/j.molimm.2018.10.016

  158. 158.
    Hydrogen Peroxide Promotes Injury-Induced Peripheral Sensory Axon Regeneration in the Zebrafish Skin · 2011
    No notice
  159. 159.

    Schäfer M, Werner S. Oxidative stress in normal and impaired wound repair. Pharm. Res. 2008;58:165-171.

    Not in our library10.1016/j.phrs.2008.06.004

  160. 160.

    Lord M, et al. Perlecan and vascular endothelial growth factor-encoding DNA-loaded chitosan scaffolds promote angiogenesis and wound healing. J. Control Rel. 2017;250:48-61.

    Not in our library10.1016/j.jconrel.2017.02.009

  161. 161.

    Seiwerth S, et al. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Curr. Pharm. Des. 2018;24:1972-1989.

    Not in our library10.2174/1381612824666180712110447

  162. 162.

    Moseley R, Stewart J, Stephens P, Waddington R, Thomas D. Extracellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases? Br. J. Dermatol. 2004;150:401-413.

    Not in our library10.1111/j.1365-2133.2004.05845.x

  163. 163.
    ROS in cancer therapy: the bright side of the moon · 2020
    No notice
  164. 164.

    Chasara, R., Ajayi, T., Leshilo, D., Poka, M. & Witika, B. Exploring novel strategies to improve anti-tumour efficiency: The potential for targeting reactive oxygen species. Heliyon9, e19896 (2023).

    Not in our library10.1016/j.heliyon.2023.e19896

  165. 165.

    Aborode, A. et al. Targeting Oxidative Stress Mechanisms to Treat Alzheimer’s and Parkinson’s Disease: A Critical Review. Oxidative Med. Cell Longev.2022, 7934442 (2022).

    Not in our library10.1155/2022/7934442

  166. 166.
    Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases · 2021
    No notice
  167. 167.

    Khan A, et al. Targeting deregulated oxidative stress in skin inflammatory diseases: An update on clinical importance. Biomed. Pharmacother. 2022;154:113601.

    Not in our library10.1016/j.biopha.2022.113601

  168. 168.
    Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds · 2020
    No notice
  169. 169.

    Duan J, Duan J, Zhang Z, Tong T. Irreversible cellular senescence induced by prolonged exposure to H2O2 involves DNA-damage-and-repair genes and telomere shortening. Int. J. Biochem. Cell Biol. 2005;37:1407-1420.

    Not in our library10.1016/j.biocel.2005.01.010

  170. 170.

    Ruan Y, Wu S, Zhang L, Chen G, Lai W. Retarding the senescence of human vascular endothelial cells induced by hydrogen peroxide: effects of 17beta-estradiol (E2) mediated mitochondria protection. Biogerontology. 2014;15:367-375.

    Not in our library10.1007/s10522-014-9507-2

  171. 171.

    Herrling T, Jung K, Fuchs J. Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2006;63:840-845.

    Not in our library10.1016/j.saa.2005.10.013

  172. 172.
    High glucose-induced oxidative stress impairs proliferation and migration of human gingival fibroblasts · 2018
    No notice
  173. 173.

    Arul V, et al. Glucose Oxidase Incorporated Collagen Matrices for Dermal Wound Repair in Diabetic Rat Models: A Biochemical Study. J. Biomater. Appl. 2012;26:917-938.

    Not in our library10.1177/0885328210390402

  174. 174.

    Zhang L, et al. A composite hydrogel of chitosan/heparin/poly (γ-glutamic acid) loaded with superoxide dismutase for wound healing. Carbohydr. Polym. 2018;180:168-174.

    Not in our library10.1016/j.carbpol.2017.10.036

  175. 175.

    Beer H, Longaker M, Werner S. Reduced Expression of PDGF and PDGF Receptors During Impaired Wound Healing. J. Investig. Dermatol. 1997;109:132-138.

    Not in our library10.1111/1523-1747.ep12319188

  176. 176.

    Kaltalioglu K, Coskun-Cevher S, Tugcu-Demiroz F, Celebi N. PDGF supplementation alters oxidative events in wound healing process: a time course study. Arch. Dermatol Res. 2013;305:415-422.

    Not in our library10.1007/s00403-013-1326-9

  177. 177.

    Lin Y, et al. Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts. J. Investig. Dermatol. 2015;135:258-268.

    Not in our library10.1038/jid.2014.288

  178. 178.

    Polouliakh N, et al. Alpha-Arbutin Promotes Wound Healing by Lowering ROS and Upregulating Insulin/IGF-1 Pathway in Human Dermal Fibroblast. Front. Physiol. 2020;11:586843.

    Not in our library10.3389/fphys.2020.586843

  179. 179.

    Quiros M, et al. Resolvin E1 is a pro-repair molecule that promotes intestinal epithelial wound healing. Proc. Natl Acad. Sci. 2020;117:9477-9482.

    Not in our library10.1073/pnas.1921335117

  180. 180.

    Chen S, et al. Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products. Eur. J. Pharm. Sci. 2012;47:875-883.

    Not in our library10.1016/j.ejps.2012.08.018

  181. 181.

    Chigurupati S, et al. Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing. Biomaterials. 2013;34:2194-2201.

    Not in our library10.1016/j.biomaterials.2012.11.061

  182. 182.

    Zhang S, et al. Polydopamine/puerarin nanoparticle-incorporated hybrid hydrogels for enhanced wound healing. Biomater. Sci. 2019;7:4230-4236.

    Not in our library10.1039/c9bm00991d

  183. 183.

    Liu T, et al. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases. Nat. Commun. 2020;11:2788.

    Not in our library10.1038/s41467-020-16544-7

  184. 184.

    Mao L, et al. In Situ Synthesized Selenium Nanoparticles‐Decorated Bacterial Cellulose/Gelatin Hydrogel with Enhanced Antibacterial, Antioxidant, and Anti‐Inflammatory Capabilities for Facilitating Skin Wound Healing. Adv. Health. Mater. 2021;10:e2100402.

    Not in our library10.1002/adhm.202100402

  185. 185.

    Kaur S, et al. Galvanic zinc–copper microparticles produce electrical stimulation that reduces the inflammatory and immune responses in skin. Arch. Dermatol Res. 2011;303:551.

    Not in our library10.1007/s00403-011-1145-9

  186. 186.

    Tandon N, et al. Galvanic microparticles increase migration of human dermal fibroblasts in a wound-healing model via reactive oxygen species pathway. Exp. Cell Res. 2014;320:79-91.

    Not in our library10.1016/j.yexcr.2013.09.016

  187. 187.

    Sahu A, Jeon J, Lee M, Yang H, Tae G. Antioxidant and anti-inflammatory activities of Prussian blue nanozyme promotes full-thickness skin wound healing. Mater. Sci. Eng C. 2021;119:111596.

    Not in our library10.1016/j.msec.2020.111596

  188. 188.

    Lee C, et al. Light-Stimulated Carbon Dot Hydrogel: Targeting and Clearing Infectious Bacteria In Vivo. ACS Appl. Bio Mater. 2022;5:761-770.

    Not in our library10.1021/acsabm.1c01157

  189. 189.

    Tur E, Bolton L, Constantine B. Topical hydrogen peroxide treatment of ischemic ulcers in the guinea pig: Blood recruitment in multiple skin sites. J. Am. Acad. Dermatol. 1995;33:217-221.

    Not in our library10.1016/0190-9622(95)90238-4

  190. 190.

    Huang X, et al. Hyperbaric oxygen potentiates diabetic wound healing by promoting fibroblast cell proliferation and endothelial cell angiogenesis. Life Sci. 2020;259:118246.

    Not in our library10.1016/j.lfs.2020.118246

  191. 191.

    Teguh D, et al. Hyperbaric oxygen therapy for nonhealing wounds: Treatment results of a single center. Wound Repair Regen. 2021;29:254-260.

    Not in our library10.1111/wrr.12884

  192. 192.

    Capó X, et al. Hyperbaric Oxygen Therapy Reduces Oxidative Stress and Inflammation, and Increases Growth Factors Favouring the Healing Process of Diabetic Wounds. Int. J. Mol. Sci. 2023;24:7040.

    Not in our library10.3390/ijms24087040

  193. 193.

    Zeng, Q., Shi, G. & Zhang, M. Real‐Time Monitoring of Wound States via Rationally Engineered Biosensors. Adv. Sens. Res.3, 2200018 (2024).

    Not in our library

  194. 194.

    Bachar-Wikstrom E, et al. Endoplasmic reticulum stress in human chronic wound healing: Rescue by 4-phenylbutyrate. Int. Wound J. 2021;18:49-61.

    Not in our library10.1111/iwj.13525

  195. 195.

    Masson-Meyers D, et al. Experimental models and methods for cutaneous wound healing assessment. Int. J. Exp. Pathol. 2020;101:21-37.

    Not in our library10.1111/iep.12346

  196. 196.

    Roy S, Khanna S, Nallu K, Hunt T, Sen C. Dermal wound healing is subject to redox control. Mol. Ther. 2006;13:211-220.

    Not in our library10.1016/j.ymthe.2005.07.684

  197. 197.

    Juarez M, Patterson R, Sandoval-Guillen E, McGinnis W. Duox, Flotillin-2, and Src42A are required to activate or delimit the spread of the transcriptional response to epidermal wounds in Drosophila. PLoS Genet. 2011;7:e1002424.

    Not in our library10.1371/journal.pgen.1002424

  198. 198.

    Son D, et al. A Novel Peptide, Nicotinyl–Isoleucine–Valine–Histidine (NA–IVH), Promotes Antioxidant Gene Expression and Wound Healing in HaCaT Cells. Mar. Drugs. 2018;16:262.

    Not in our library10.3390/md16080262

  199. 199.

    Frykberg R, et al. Use of Topical Oxygen Therapy in Wound Healing. J. Wound Care. 2023;32:S1-S32.

    Not in our library10.12968/jowc.2023.32.sup8b.s1

Cited by papers we hold 1

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.